- Home
- IQV vs LYV Comparison
IQV vs LYV Comparison
Compare IQV & LYV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- LYV
- Stock Information
- Founded
- IQV 1982
- LYV 2005
- Country
- IQV United States
- LYV United States
- Employees
- IQV N/A
- LYV N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- LYV Services-Misc. Amusement & Recreation
- Sector
- IQV Health Care
- LYV Consumer Discretionary
- Exchange
- IQV Nasdaq
- LYV Nasdaq
- Market Cap
- IQV 35.7B
- LYV 33.6B
- IPO Year
- IQV 2013
- LYV N/A
- Fundamental
- Price
- IQV $190.98
- LYV $149.36
- Analyst Decision
- IQV Strong Buy
- LYV Strong Buy
- Analyst Count
- IQV 17
- LYV 17
- Target Price
- IQV $251.00
- LYV $156.06
- AVG Volume (30 Days)
- IQV 1.4M
- LYV 2.2M
- Earning Date
- IQV 02-06-2025
- LYV 02-20-2025
- Dividend Yield
- IQV N/A
- LYV N/A
- EPS Growth
- IQV 2.74
- LYV 99.52
- EPS
- IQV 7.49
- LYV 2.73
- Revenue
- IQV $15,405,000,000.00
- LYV $23,155,625,000.00
- Revenue This Year
- IQV $5.17
- LYV $2.61
- Revenue Next Year
- IQV $6.04
- LYV $15.09
- P/E Ratio
- IQV $25.51
- LYV $54.94
- Revenue Growth
- IQV 2.81
- LYV 1.79
- 52 Week Low
- IQV $187.62
- LYV $86.81
- 52 Week High
- IQV $261.73
- LYV $157.75
- Technical
- Relative Strength Index (RSI)
- IQV 37.76
- LYV 59.76
- Support Level
- IQV $192.10
- LYV $144.58
- Resistance Level
- IQV $198.90
- LYV $155.10
- Average True Range (ATR)
- IQV 5.43
- LYV 3.79
- MACD
- IQV -1.28
- LYV -0.11
- Stochastic Oscillator
- IQV 0.75
- LYV 49.91
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About LYV Live Nation Entertainment Inc.
Live Nation is the largest live entertainment company in the world, serving as a concert promoter, venue operator, and ticketing platform. In addition, the firm generates revenue from sponsorships and advertising. With offices in 45 countries, Live Nation promotes concerts globally and it owns, operates, or had exclusive booking rights to 373 venues worldwide at the end of 2023, which the firm says makes it the second-largest operator of music venues globally. In 2023, Live Nation promoted more than 50,000 events, drawing more than 145 million fans. Ticketmaster is a dominant global ticketing service, selling more than 620 million tickets in 2023.